A gene signature specific for intestinal stem cells (ISCs) has recently been shown to predict relapse in colorectal cancer (CRC) but the tumorigenic role of individual signature genes remains poorly defined. A prominent ISC-signature gene is the cancer stem cell marker CD44, which encodes various splice variants comprising a diverse repertoire of adhesion and signaling molecules. Using Lgr5 as ISC marker, we have fluorescence-activated cell sorting-purified ISCs to define their CD44 repertoire. ISCs display a specific set of CD44 variant isoforms (CD44v), but remarkably lack the CD44 standard (CD44s) isoform. These CD44v also stand-out in transformed human ISCs isolated from microadenomas of familial adenomatous polyposis patients. By employing knock-in mice expressing either CD44v4-10 or CD44s, we demonstrate that the CD44v isoform, but not CD44s, promotes adenoma initiation in Apc Min/ þ mice. Our data identify CD44v as component of the ISCs program critical for tumor initiation, and as potential treatment target in CRC.
INTRODUCTION
The self-renewal of the intestinal epithelium is a tightly controlled dynamic process. Intestinal stem cells (ISCs) residing at the crypt base divide once a day and their daughter cells form a transitamplifying (TA) compartment of rapidly replicating progenitor cells, which differentiate into enterocytes, goblet-, paneth-, or enteroendocrine cells. 1 Wnt signaling has a key role in maintaining the ISC compartment, 2, 3 while the vast majority of colorectal cancers (CRCs) are initiated by mutations in the Wnt pathway 4 causing constitutive transcriptional activation of Wnt/TCF target genes. [5] [6] [7] Microarray based gene-expression studies have defined a core target-gene set activated by Wnt/TCF in intestinal epithelial cells; [8] [9] [10] a subset of these genes showed expression restricted to ISCs. 11 Activating Wnt pathway mutations in ISCs give rise to intestinal adenomas with a much higher efficacy than in other intestinal epithelial cell populations, 7 while CRC cells with an ISC-like signature are endowed with high-tumor initiating potential as well as long-term self-renewal capacity, 12 implying an instrumental role for ISC signature genes in tumorigenesis.
A prominent component of the ISC signature is CD44, a gene that has first been associated with CRC metastasis and relapse almost two decades ago. [13] [14] [15] CD44 comprises a family of transmembrane glycoproteins generated from a single gene by extensive alternative splicing and differential glycosylation. 16 These proteins operate as cell adhesion and signaling (co)receptors, linking extracellular matrix (ECM) components, specifically hyaluronan and osteopontin, to the cell and cytoskeleton. 16 By modulating growth factor receptor signaling [16] [17] [18] they exert pleiotropic effects on important biological processes including cell migration, epithelial to mesenchymal transition, cancer metastasis and apoptosis resistance. 16, 18, 19 In the intestinal mucosa, CD44 is a major direct target of TCF/b-catenin mediated transcription 9, 10, 20 (Figure 1a ), while several lines of evidence suggest an important role in intestinal cancer. Dalerba and coworkers demonstrated that CD44 marks human CRC cells with cancer stem cell properties 21 and our own recent studies have shown that deletion of CD44 in Apc Min/ þ mice strongly attenuates intestinal tumor initiation. 22 Furthermore, in clinical CRC samples, high expression levels of CD44 variant isoforms (CD44v) on the primary tumor have been associated with tumor recidives at distant sites and poor prognosis. 23 Collectively, these studies indicate that CD44 has an important role in intestinal tumorigenesis, which is associated with ISC fate. However, to date, the identity and contribution of different CD44 isoforms, which present potential treatment targets in CRC patients remains unexplored. 16 Here, we report the characterization of the CD44 expression repertoire of ISCs. By generating Apc Min/ þ mice exclusively expressing CD44s or CD44v, we identify a specific CD44v isoform as component of the ISC signature instrumental in tumor initiation.
RESULTS AND DISCUSSION
To identify the variant isoforms that constitute the CD44 repertoire of ISCs, epithelial cells were isolated from the small intestinal crypts of Lgr5-GFP mice 24 ( Figure 1b ). Single cells were sorted by fluorescence-activated cell sorting into three distinct subpopulations: GFP-high, GFP-medium and GFP-low (Figure 1c),  representing pure ISCs, an intermediate fraction, and TA cells,  respectively. 11,24 CD44 pre-mRNA is encoded by 20 exons, 10 of which are subject to extensive alternative splicing (variant exons v1 through v10, Figure 1d ), generating multiple differentially spliced mRNA transcripts. The composition of these transcripts was resolved by using exon-specific real-time PCR. 25 This analysis revealed that the TA and intermediate cell fractions express mRNAs encoding CD44v6-10, CD44v7-10 and CD44v8-10, whereas the GFP-high ISC fraction expressed an additional isoform identified as CD44v4-10 ( Figure 1e) . Unexpectedly, the GFP-high ISCs did not express the standard form of CD44 (CD44s), a common isoform reported to be widely expressed by many tissues/cell types including primary CRCs and CRC cell lines. 13, 20 Quantitative analysis by quantitative real-time PCR, revealed that the GFP-high ISC cell fraction expresses five to sixfold higher levels of CD44v6, CD44v4, and total CD44 than the GFP-low (TA) fraction (Figure 1f ). Exon spanning primers specific for CD44s failed to generate an amplification product (data not shown), confirming the absence of CD44s expression. Expression of the stem cell signature genes Olfm4 and Ascl2 was almost exclusively restricted to the GFP-high cell fraction (Figure 1f ), corroborating that these cells represent ISCs. These findings identify a limited and distinct repertoire of CD44v in ISCs, the largest isoform being CD44v4-10.
To explore whether human ISCs display a comparable CD44 repertoire, we analyzed epithelial cells from dysplastic aberrant crypt foci of familial adenomatous polyposis patients. Due to mutational activation of the Wnt pathway, these microadenomas retain a stem cell program. 10 In accordance, immunohistochemical staining using monoclonal anti-CD44v6 antibody showed a strong induction of CD44v in almost all epithelial cells of aberrant crypt foci (Figure 2a ). Epithelial cells from the basal crypt region of normal colon and from aberrant crypt foci were isolated by using Supplementary Table S1 . (e) Exon-specific real-time PCR analysis for the expression of murine CD44 variant exons in GFP-high (top panel) and GFP-low cells (lower panel). The PCR protocol was analogous to that from van Weering et al. 25 The lane indicated by 'c' shows PCR products obtained by using primers spanning all variant exons. The arrow indicates CD44s product and no visible band for CD44s is indicated by an asterisk. Lane 'm' shows a 100-bp DNA ladder. (f ) Quantitative real-time PCR results showing relative gene expression levels in each subpopulation for respectively, Cd44v6, Cd44v4, and total Cd44, as well as Olfm4 and Ascl2. Quantitative real-time PCR data were obtained on a Roche LightCycler 1.5 using FastStart DNA Master SYBR Green I kit (Roche Molecular Systems, Inc, CA, USA) and was analyzed using LinReg software. 36 Results were normalized to b-actin. Error bars indicate s.e.m. Primers are listed in Supplementary Table S1 .
laser-capture microdissection (Supplementary Figure S1) . Similar to murine ISCs, exon-specific real-time PCR and quantitative realtime PCR analysis of these microadenomas revealed a prominent expression of mRNA encoding CD44v, including CD44v4-10 ( Figures 2b and c) , suggesting involvement at early stages of human CRC.
The above findings strongly suggest an instrumental role for ISC specific CD44v isoforms in intestinal cancer formation. To explore this role, we generated knock-in mice exclusively expressing either CD44v4-10, being the largest isoform detected in ISCs, or as control, CD44s. Two gene replacement targeting vectors containing a partial genomic Cd44 clone were constructed (Figure 3a) and homologs recombination in embryonic stem cells resulted in mice solely expressing either CD44v4-10 (Cd44 v4-10/v4-10 mice) or CD44s (Cd44 s/s mice; Figure 3b and c). The Cd44 knock-in mice were fertile and showed no gross abnormalities. Flow cytometric analysis of purified crypt cells using the antipan CD44 mAb IM7 showed comparable expression of CD44 in the intestinal epithelium of adult mice (Figure 3d ), while immunohistochemical staining of intestinal tissue sections confirmed that the CD44 proteins were expressed in the stem cell compartments (Figure 3e) . A detailed analysis of the intestines revealed no abnormalities in crypt/villus length ratio's, number of cycling crypt-base columnar and TA cells, or apoptotic cell numbers in the crypt compartment (Supplementary Figure S2) . The latter findings are consistent with the previously reported absence of intestinal abnormalities in CD44-deficient mice. 22 To study the effect of CD44v on intestinal tumorigenesis, Cd44 À / À /Apc Min/ þ ) were also employed. Mice were sacrificed at 8 weeks of age (n ¼ 14 per group) and the number of adenomas in the intestinal tracts was assessed by operation binoculars. In addition, micro-adenomas were counted in hematoxylin and eosin stained tissue sections of intestine embedded as 'Swiss rolls'. All intestinal adenomas were of the (tubulo)villous type and a similar anatomical distribution, with a preferential localization in the distal part of the small intestine, was found for all genotypes mice. Single crypt cells were isolated as described previously 11 and were analyzed by flow cytometry. Pan-epithelial surface antigen EpCAM was used to confirm epithelial cell populations (499% purity). Pan-CD44 mAb IM7 (BD Pharmingen, CA, USA) was used tot determine the cell surface expression of CD44. (e) CD44 protein expression in the crypt compartments of Cd44
, and Cd44 v4-10/v4-10 mice. Total CD44 expression was detected by immunohistochemical staining using the anti-pan CD44 mAb IM7. TA-cells (arrows) and crypt-base columnar (CBC) cells (circled) are indicated in the CD44 variant knock-in mice (scale bar ¼ 50 mm). Figure 4a ), comparable to adenoma numbers reported in earlier studies. 22, 26 The Cd44 -/-/Apc Min/ þ animals showed an over twofold reduction in adenoma formation (18.3 ± 2.5, Po0.001), confirming our previous finding that CD44 deletion strongly attenuates adenoma initiation. 22 In the Cd44 s/s /Apc Min/ þ knock-in mice adenoma numbers were not different from that in CD44-deficient mice (21.6 ± 4.6, P ¼ 0.53). In marked contrast, however, adenoma formation in the Cd44 v4-v10/v4-v10 /Apc Min/ þ knock-in mice was enhanced significantly compared with that in CD44-deficient mice and was similar to that in Apc Min/ þ animals with wild-type CD44 (34.5±5.9, Po0.05 compared with Cd44 À / À /Apc Min/ þ mice and P ¼ 0.43 compared with Cd44 þ / þ /Apc Min/ þ mice). Also in mice heterozygous for CD44v4-10, significantly enhanced adenoma formation as compared with Cd44 -/-/Apc Min/ þ mice was found (30±3.7, Po0.05). These results show that expression of CD44v4-10, but not CD44s, restores the wild-type phenotype of adenoma formation, implying that this stem-cell signature associated CD44v isoform is functionally involved in intestinal tumorigenesis. Like the formation of (macro)adenomas, microadenoma formation was also significantly impaired in CD44-deficient and CD44s mice, and could be completely restored by CD44v4-10 (Figure 4b) , suggesting a role for CD44v in tumor initiation rather than in adenoma outgrowth. Interestingly, survival analysis performed in a separate group of mice revealed that the attenuated adenoma formation in Apc Min/ þ lacking CD44v results in a significant survival advantage (Figure 4c) .
Our previous observations suggested that, CD44 controls intestinal tumor formation by affecting apoptosis resistance in the crypt compartments of Apc Min/ þ mice. 22 Specifically, Apc
Min/ þ mice lacking CD44 showed an increased number of apoptotic cell numbers in the intestinal crypts compared with Cd44
Min/ þ mice, but interestingly, also with Cd44
, indicating that neither the absence of CD44 nor the presence of an Apc Min allele per se affect crypt cell apoptosis. Assaying apoptosis within the basal crypt compartments of the Apc Min mutant animals revealed no differences between the Cd44
v4-10/v4-10 -expressing groups, however, similar to that previously reported, Cd44
À / À -Apc Min/ þ mice exhibited an increase in apoptotic cell numbers (Supplementary Figure S3) . No growth or cell cycle abnormalities were observed. These results indicate that all CD44 isoforms control cell survival in the intestinal crypt epithelium to a similar degree and suggest that the regulation of apoptosis by CD44 does not contribute to intestinal tumorigenesis.
Our study demonstrates an instrumental role for CD44v in intestinal tumorigenesis. CD44v4-10 represents the longest isoform identified in ISCs and the fact that this ISC CD44 isoform promotes adenoma formation, presumably by acting on tumor initiation, supports the concept that ISCs are the cells of origin of intestinal cancer. 7 Importantly, CD44 variants, including CD44v4-10, were also prominently expressed in neoplastic epithelial cells from early lesions of familial adenomatous polyposis patients, suggesting that these isoforms are also implicated in human CRC. By contrast, murine ISCs and their human neoplastic counterparts are CD44s negative/low and our in vivo studies demonstrate that CD44s cannot compensate for the negative effect of CD44 deficiency on adenoma initiation in Apc Min/ þ mice. The results of earlier studies which reported expression of CD44s in primary CRC as well as in CRC cell lines 13, 20, 27 presumably reflect the presence of more differentiated (non-ISC) cell populations within the tumor.
Although the vast complexity of CD44 prohibits definitive mechanistic conclusions, CD44 has several biological functions that are of potential value for stem cells and could promote tumor initiation. As a mediator of bidirectional signaling between the ECM and the cytoskeleton, CD44 controls crosstalk between transmembrane and cytoplasmic molecules. In these interactions, it functions as a potent signal amplifier, specifically of receptor tyrosine kinase signaling. 16 For example, CD44v isoforms are required for effective hepatocyte growth factor (HGF)-induced signal transduction through the receptor tyrosine kinase MET in several cell types including colon cancer cells (CSCs). 18, 27 HGF is a potent mitogen and survival factor as well as a key mediator of epithelial to mesenchymal transition. 28 In colon cancer, numbers assessed in hematoxylin and eosin stain stained intestinal sections at 8-weeks (mean ± s.e.m.; n ¼ 14 per group; *Po0.05; **Po0.01; ***Po0.001). Small intestine and colon were flushed with phosphate-buffered saline, opened longitudinally and examined using an operation binocular. Adenomas were assessed by two independent experienced observers and were classified according to standard criteria. 26 For statistical analysis, the Mann À Whitney test was used. (c) Kaplan À Meier curves showing the relation between Cd44 genotype and survival in Apc Min/ þ mice. Survival of mice lacking Cd44v (Cd44 À / À and Cd44 s/s ) was significantly prolonged compared with mice having CD44v (Cd44 þ / þ and Cd44 v4-10/v4-10 ) (Po0.01). Mice were inspected daily and sacrificed when sign of illness appeared (rectal prolapse, weight loss, anemia).
Curves were compared by log-rank test. All mice strains were determined to be Mom-1 and Mom-2 susceptible, both loci are major modifiers of the Apc Min/ þ phenotype in C57BL/6 J mice.
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CD44v in intestinal cancer J Zeilstra et al MET is frequently overexpressed by the tumor cells while HGF is expressed by myofibroblasts at the invasive front of the tumor. 29, 30 Like CD44 expression, expression of MET is controlled by the Wnt pathway, and MET overexpression at the initial stage of CRC results from enhanced Wnt signaling. 10, 31 Interestingly, a recent study by Vermeulen et al. 32 suggests a pivotal role for HGF in determining stemness of CSCs: High Wnt activity functionally designates CSCs and can be regulated by myofibroblast-secreted HGF, indicating that stemness of CSCs is in part orchestrated by the microenvironment. CD44v could be a crucial player in this scenario as it is critical for MET signaling in HT-29 CRC cells. 27 Indeed, we have recently obtained evidence for functional collaboration between CD44v and MET in the mouse intestinal stem cell compartment and in human colorectal CSCs (unpublished observations). Apart from affecting tyrosine kinase viz. HGF/MET signaling, CD44v might also modulate cellular functions by modulating interaction with ECM. CD44 splicing can regulate interaction with its main ligand, hyaluronan. 17, 33 As ISCs reside in a niche that abounds in ECM molecules, including hyaluronate, 34 alterations in adhesion might affect stemness, proliferation and apoptosis resistance. Furthermore, CD44-ECM interaction could affect intestinal stromal cell function and this can contribute to malignant transformation in an indirect manner, for instance, by regulating sensitivity for inflammation. 35 Irrespective of the precise mechanism(s), however, our current findings demonstrate that CD44v marks ISCs and is instrumental in intestinal adenoma formation. These findings are of great interest as they specify and functionally underpin a number of recent studies which have identified CD44 as an important marker for colon carcinoma cells with tumor-initiating properties, 21 as well as for tumor initiating cells in several other solid cancers and leukemia. 16 In contrast to the standard form of CD44, which is ubiquitously expressed by many different cell types, expression of CD44v is highly restricted in normal tissue. 16 Thus, the current findings may also provide a novel handle for targeted treatment aiming to suppress tumorigenic and metastatic properties in cancer.
